Does Trulicity cause hair loss? This is a common concern among patients prescribed this type 2 diabetes medication. Hair loss is not listed as a recognised side effect of Trulicity (dulaglutide) in official prescribing information from the MHRA or EMA. However, some patients report hair thinning whilst taking this GLP-1 receptor agonist. Understanding the potential indirect mechanisms—including weight changes, nutritional factors, and diabetes-related issues—can help you and your healthcare provider determine the true cause and appropriate management if you experience hair shedding during treatment.

Does Trulicity Cause Hair Loss?

Hair loss is not listed as a common or recognised side effect of Trulicity (dulaglutide) in the official prescribing information approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA). Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes. The medication has a well-documented side effect profile that does not include alopecia as a direct adverse reaction.

However, some patients taking Trulicity have reported experiencing hair thinning or shedding. There is no official link established between Trulicity and hair loss, and such reports remain anecdotal rather than evidence-based. It is important to understand that hair loss can occur for numerous reasons unrelated to medication, including nutritional deficiencies, hormonal changes, stress, underlying medical conditions, or natural ageing processes.

When patients experience hair loss whilst taking Trulicity, it may be related to weight changes rather than the medication itself. Weight reduction—which can occur when using GLP-1 receptor agonists—might potentially trigger a condition called telogen effluvium, a temporary form of hair shedding. Additionally, people with type 2 diabetes may have other concurrent health issues that independently affect hair health.

If you are concerned about hair loss whilst taking Trulicity, it is essential to consult your GP or diabetes specialist. They can assess whether the hair loss is related to your medication, your diabetes management, nutritional status, or another underlying cause. Do not discontinue Trulicity without medical advice, as this may compromise your diabetes control.

If you suspect Trulicity may be causing side effects, you can report this through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Understanding Trulicity and Its Common Side Effects

Trulicity (dulaglutide) is a once-weekly injectable medication belonging to the GLP-1 receptor agonist class. It works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and reduces appetite. These mechanisms help lower blood glucose levels in people with type 2 diabetes, which is the licensed indication for Trulicity in the UK.

According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported side effects of Trulicity are gastrointestinal in nature. These include:

• Nausea (very common, particularly at higher doses)

• Diarrhoea (very common)

• Vomiting (common)

• Abdominal pain or discomfort (common)

• Decreased appetite (common)

• Constipation (common)

These gastrointestinal symptoms are typically most pronounced when starting treatment or increasing the dose, and often improve over time as the body adjusts to the medication. Maintaining hydration and eating small, frequent meals while avoiding fatty or spicy foods may help manage these effects.

Other recognised side effects include injection site reactions (redness, itching, or swelling), fatigue, and dizziness. More serious but rare adverse effects include pancreatitis and hypoglycaemia (particularly when used with insulin or sulphonylureas). The SmPC also includes precautionary information about gallbladder disease and thyroid C-cell tumours (based on animal studies, though the relevance to humans remains unclear).

According to NICE guidance, patients should be counselled about these common side effects before starting Trulicity and advised to report any persistent or severe symptoms. Hair loss does not feature in the official list of adverse reactions in the SmPC, suggesting that if it occurs, it is likely due to indirect factors rather than a direct pharmacological effect of dulaglutide.

Patients are encouraged to report any suspected side effects to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Why Hair Loss May Occur During Trulicity Treatment

Although Trulicity itself is not known to cause hair loss directly, several indirect mechanisms may explain why some patients experience hair thinning or shedding whilst taking this medication.

Weight loss and telogen effluvium are possible explanations. Trulicity can lead to some weight reduction as a secondary effect of treatment. Significant weight changes, especially when accompanied by caloric restriction, can trigger telogen effluvium, a condition where hair follicles prematurely enter the resting (telogen) phase of the hair growth cycle. This results in increased shedding approximately 2–4 months after the triggering event. Telogen effluvium is typically temporary, and hair growth usually resumes once weight stabilises and nutritional balance is restored.

Nutritional factors may also contribute to hair loss in patients taking Trulicity. The medication's appetite-suppressing effects can lead to reduced food intake, potentially resulting in inadequate consumption of essential nutrients important for healthy hair growth. Iron deficiency is particularly relevant, with ferritin levels being an important marker to check in cases of unexplained hair loss.

Underlying diabetes-related factors should not be overlooked. Type 2 diabetes itself can affect hair health through poor circulation, hormonal imbalances, and chronic inflammation. Additionally, stress—whether physical (from illness) or psychological—can exacerbate hair shedding.

Other concurrent medications or medical conditions may also play a role. Patients with diabetes often take multiple medications, some of which may influence hair health. For example, metformin can affect vitamin B12 absorption, as noted in MHRA safety updates, and B12 deficiency may contribute to hair problems. Thyroid disorders, anaemia, and autoimmune conditions are more common in people with diabetes and can independently cause hair loss.

It is important to note that correlation does not imply causation. Just because hair loss occurs whilst taking Trulicity does not mean the medication is responsible. A thorough clinical assessment is necessary to identify the true underlying cause.

What to Do If You Experience Hair Loss on Trulicity

If you notice increased hair shedding or thinning whilst taking Trulicity, do not stop your medication without consulting your healthcare provider. Discontinuing Trulicity abruptly may lead to worsening blood glucose control and compromise your diabetes management.

Contact your GP or diabetes specialist to discuss your concerns. They will likely:

• Review your medical history and current medications to identify potential causes

• Assess the pattern and timing of hair loss (e.g., diffuse thinning versus patchy loss)

• Evaluate your nutritional status, particularly if you have experienced weight changes

• Arrange appropriate blood tests which may include full blood count, ferritin, and thyroid function tests as first-line investigations

• Consider vitamin B12 levels, especially if you are taking metformin

• Examine your scalp for signs of dermatological conditions

Nutritional optimisation is important if deficiencies are identified. Ensure your diet includes:

• Adequate protein (lean meats, fish, eggs, legumes, dairy)

• Iron-rich foods (red meat, dark leafy greens, fortified cereals)

• B vitamins (eggs, nuts, whole grains)

• Essential minerals from a varied diet

Your healthcare provider may recommend nutritional supplements if specific deficiencies are identified through blood tests, rather than taking supplements indiscriminately.

Monitor your hair loss pattern. If it is due to telogen effluvium related to weight changes or stress, shedding typically peaks around 3–4 months after the triggering event and then gradually improves over the following 6–12 months as hair follicles return to their normal growth cycle.

Seek prompt medical advice if you experience:

• Patchy bald spots with inflammation

• Scalp pain, itching, or burning

• Hair loss accompanied by other symptoms such as fatigue, palpitations, or changes in skin or nails

Consider specialist referral if hair loss persists beyond 6 months despite addressing potential causes, or if there are signs of scarring alopecia.

Your healthcare team can work with you to balance effective diabetes management with addressing any side effects or concerns, ensuring your overall health and wellbeing remain the priority. Remember to report any suspected side effects to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Frequently Asked Questions